| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/JNR.24141 |
| P698 | PubMed publication ID | 28877366 |
| P50 | author | Joyce A Benjamins | Q88922293 |
| P2093 | author name string | Robert P Lisak | |
| Liljana Nedelkoska | |||
| P2860 | cites work | Further structure-activity studies of lactam derivatives of MT-II and SHU-9119: their activity and selectivity at human melanocortin receptors 3, 4, and 5 | Q24674161 |
| ACTH Antagonists | Q26740152 | ||
| ACTH: The forgotten therapy | Q28258012 | ||
| The Melanocortin Receptor System: A Target for Multiple Degenerative Diseases | Q28273671 | ||
| Neuroprotective actions of melanocortins: a therapeutic opportunity | Q28283714 | ||
| The current evaluation and treatment of infantile spasms among members of the Child Neurology Society | Q30455995 | ||
| Binding of cholera toxin B subunit: a surface marker for murine microglia but not oligodendrocytes or astrocytes | Q32027913 | ||
| Adrenocorticotropic hormone versus methylprednisolone added to interferon β in patients with multiple sclerosis experiencing breakthrough disease: a randomized, rater-blinded trial | Q33589934 | ||
| Monoclonal antibody to a plasma membrane antigen of neurons | Q34034864 | ||
| Discovery of tyrosine-based potent and selective melanocortin-1 receptor small-molecule agonists with anti-inflammatory properties | Q34184691 | ||
| A glial progenitor cell that develops in vitro into an astrocyte or an oligodendrocyte depending on culture medium | Q34254567 | ||
| New substituted piperazines as ligands for melanocortin receptors. Correlation to the X-ray structure of "THIQ". | Q34341942 | ||
| Effect of NDP-α-MSH on PPAR-γ and -β expression and anti-inflammatory cytokine release in rat astrocytes and microglia | Q34612008 | ||
| Targeting melanocortin receptors as a novel strategy to control inflammation. | Q35682900 | ||
| Mechanisms of action of adrenocorticotropic hormone and other melanocortins relevant to the clinical management of patients with multiple sclerosis | Q36613389 | ||
| Studies on the physiological functions of the melanocortin system | Q36640631 | ||
| Alpha-melanocyte-stimulating hormone and related tripeptides: biochemistry, antiinflammatory and protective effects in vitro and in vivo, and future perspectives for the treatment of immune-mediated inflammatory diseases | Q37210818 | ||
| Distribution and function of melanocortin receptors within the brain | Q37827455 | ||
| Adrenocorticotropic hormone for the treatment of West Syndrome in children | Q38100763 | ||
| Infantile spasms syndrome, West syndrome and related phenotypes: what we know in 2013. | Q38165574 | ||
| Molecular evolution of GPCRs: Melanocortin/melanocortin receptors | Q38215494 | ||
| Multiple beneficial effects of melanocortin MC4 receptor agonists in experimental neurodegenerative disorders: Therapeutic perspectives. | Q39028990 | ||
| Melanocortin-1 receptor activation is neuroprotective in mouse models of neuroinflammatory disease. | Q40474467 | ||
| Galactocerebroside is a specific cell-surface antigenic marker for oligodendrocytes in culture | Q40925821 | ||
| Monoclonal antibodies (O1 to O4) to oligodendrocyte cell surfaces: an immunocytological study in the central nervous system | Q42799087 | ||
| Proligodendroblast antigen (POA), a developmental antigen expressed by A007/O4-positive oligodendrocyte progenitors prior to the appearance of sulfatide and galactocerebroside | Q43899714 | ||
| ACTH protects mature oligodendroglia from excitotoxic and inflammation-related damage in vitro | Q44511847 | ||
| Treatment of cerebral ischemia with melanocortins acting at MC4 receptors induces marked neurogenesis and long-lasting functional recovery | Q44880939 | ||
| Prevention and treatment of experimental autoimmune encephalomyelitis with recombinant adeno-associated virus-mediated alpha-melanocyte-stimulating hormone-transduced PLP139-151-specific T cells | Q45410674 | ||
| Generation of expression constructs that secrete bioactive alphaMSH and their use in the treatment of experimental autoimmune encephalomyelitis | Q45858695 | ||
| The melanocortin ACTH 1-39 promotes protection of oligodendrocytes by astroglia | Q46585013 | ||
| Melanocortin receptor agonist ACTH 1-39 protects rat forebrain neurons from apoptotic, excitotoxic and inflammation-related damage | Q46680347 | ||
| Effects of dextromethorphan on glial cell function: proliferation, maturation, and protection from cytotoxic molecules | Q46932015 | ||
| Activation of melanocortin 4 receptors reduces the inflammatory response and prevents apoptosis induced by lipopolysaccharide and interferon-gamma in astrocytes | Q48124765 | ||
| Differential effects of Th1, monocyte/macrophage and Th2 cytokine mixtures on early gene expression for immune-related molecules by central nervous system mixed glial cell cultures. | Q51586474 | ||
| The melanocortin system in control of inflammation. | Q55426694 | ||
| P433 | issue | 3 | |
| P921 | main subject | oligodendrocyte | Q916698 |
| P304 | page(s) | 427-435 | |
| P577 | publication date | 2017-09-06 | |
| P1433 | published in | Journal of Neuroscience Research | Q6295654 |
| P1476 | title | Melanocortin receptor subtypes are expressed on cells in the oligodendroglial lineage and signal ACTH protection | |
| P478 | volume | 96 |
| Q41552761 | Melanocortins, Melanocortin Receptors and Multiple Sclerosis | cites work | P2860 |
Search more.